According to Kala Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -โน3.25 B. In 2023 the company made an earning of -โน3.55 B an increase over its 2022 earnings that were of -โน3.77 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.